Use of Normal Saline With or Without Dextrose During Induction of Labor in Nulliparous
DEXTRONS
Utilisation parentérale de Normal Salin Avec ou Sans Dextrose Durant l'Induction du Travail Chez Les Nullipares
1 other identifier
interventional
200
1 country
1
Brief Summary
The objective of this study is to compare the effects of use of normal saline (250 cc / h), with or without dextrose supplement, on the evolution of labor in nulliparous.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 4, 2015
CompletedFirst Posted
Study publicly available on registry
January 14, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedOctober 31, 2016
October 1, 2016
3.2 years
March 4, 2015
October 27, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
2nd stage of labor
during delivery of a first baby, for an average of 5 hours
Study Arms (2)
control
ACTIVE COMPARATORnormal saline, 250 ml/h, until expulsion of placental
intervention
EXPERIMENTALnormal saline + 5% dextrose, 250 ml/h, until expulsion of placental
Interventions
women with an elective induction of labor receive IV hydratation (250 ml/h) with a normal saline solution + 5% dextrose
women with an elective induction of labor receive IV hydratation (250 ml/h) with a normal saline solution
Eligibility Criteria
You may qualify if:
- nulliparous woman
- monofetal pregnancy
- delivery at term
- elective induction
- favorable cervix (Bishop score of at least 6)
- cephalic presentation
You may not qualify if:
- diabetes
- preeclampsia
- maternal heart disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, J1H 5N4, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yves-André Bureau, MD
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2015
First Posted
January 14, 2016
Study Start
January 1, 2013
Primary Completion
March 1, 2016
Study Completion
September 1, 2016
Last Updated
October 31, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will share
Oral presentation at the Society of Maternal and Fetal Medicine annual meeting (January 2017, Las Vegas) Manuscript in preparation